Phospholipase A(2) as a therapeutic target for atherosclerosis

Erstveröffentlichung
2010Authors
Karakas, Mahir
Koenig, Wolfgang
Wissenschaftlicher Artikel
Published in
CLINICAL LIPIDOLOGY ; 5 (2010), 1. - S. 43-56. - ISSN 1758-4299. - eISSN 1758-4302
Link to publication
https://dx.doi.org/10.2217/clp.09.74Institutions
UKU. Klinik für Innere Medizin IISubject headings
[Free subject headings]: atherosclerosis | darapladib | inflammation | lipoprotein-associated | phospholipase A(2) | secretory phospholipase A(2) | varespladib | LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE-A2 | LOW-DENSITY-LIPOPROTEIN | CORONARY-HEART-DISEASE | ACTIVATING-FACTOR ACETYLHYDROLASE | C-REACTIVE PROTEIN | FUTURE CARDIOVASCULAR EVENTS | GROUP-II PHOSPHOLIPASE-A(2) | MIDDLE-AGED MEN | GROUP-V | SECRETORY PHOSPHOLIPASE-A2[DDC subject group]: DDC 570 / Life sciences
Metadata
Show full item recordThis could also interest you:
-
Funktionelle Charakterisierung der Interaktion von RhoH mit den Phospholipasen C-beta2 und -gamma2
Löschmann, Yvonne Yi-Na (2016)Dissertation
-
Noncatalytic Bruton's tyrosine kinase activates PLC?(2) variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells
Wist, Martin et al. (2020)Wissenschaftlicher Artikel
-
Strukturelle Voraussetzungen der Rac2-vermittelten Aktivierung der Phospholipase C-gamma2
Christow, Carolin (2011)Dissertation